Sun Pharmaceutical Industries, Inc. received FDA approval to market the generic version of TRAMADOL HYDROCHLORIDE oral tablets, continuing the company's strategic push into the expansive opioid marketplace and intensifying generic competition for the widely utilized pain medication.